Mammographic microcalcifications and breast cancer tumorigenesis: A radiologic-pathologic analysis

BMC Cancer

Volumn 15, Issue 1, 2015, Pages

  Naseem, Madiha ^a,b   Murray, Joshua ^c   Hilton, John F ^d   Karamchandani, Jason ^a,b   Muradali, Derek ^a,b   Faragalla, Hala ^a,b   Polenz, Chanele ^a   Han, Dolly ^a   Bell, David C ^a   Brezden Masley, Christine ^a,b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MONCTON HOSPITAL   (Canada)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Breast imaging; Breast pathology; HER 2; Mammography; Microcalcifications; Tumorigenesis

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CALCIFICATION; BREAST CARCINOGENESIS; BREAST CARCINOMA; BREAST DENSITY; CANCER GRADING; CANCER SCREENING; CLIMACTERIUM; CONTROLLED STUDY; CORRELATIONAL STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MEDICAL RECORD REVIEW; MULTIPLE CANCER; PROTEIN EXPRESSION; BREAST TUMOR; CALCINOSIS; CARCINOGENESIS; DIAGNOSTIC IMAGING; MIDDLE AGED; PATHOLOGY; PROCEDURES; RETROSPECTIVE STUDY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CALCINOSIS; CARCINOGENESIS; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84928550419     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/s12885-015-1312-z     Document Type: Article

References (23)

1. Breast cancer statistics. [http://www.cancer.ca].
2. Tabar L, Duffy SW, Vitak B, Chen HH, Prevost TC. The natural history of breast carcinoma: what have we learned from screening? Cancer. 1999;86(3):449-62.
3. Bellahcene A, Castronovo V. Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer. Am J Pathol. 1995;146(1):95-100.
4. Nalawade YV. Evaluation of breast calcifications. Indian J Radiol Imaging. 2009;19(4):282-6.
5. Bansal GJ, Thomas KG. Screen-detected breast cancer: does presence of minimal signs on prior mammograms predict staging or grading of cancer? Clin Radiol. 2011;66(7):605-8.
6. Castronovo V, Bellahcene A. Evidence that breast cancer associated microcalcifications are mineralized malignant cells. Int J Oncol. 1998;12(2):305-8.
7. Morgan MP, Cooke MM, McCarthy GM. Microcalcifications associated with breast cancer: an epiphenomenon or biologically significant feature of selected tumors? J Mammary Gland Biol Neoplasia. 2005;10(2):181-7.
8. Zunzunegui RG, Chung MA, Oruwari J, Golding D, Marchant DJ, Cady B. Casting-type calcifications with invasion and high-grade ductal carcinoma in situ: a more aggressive disease? Arch Surg. 2003;138(5):537-40.
9. Palka I, Ormandi K, Gaal S, Boda K, Kahan Z. Casting-type calcifications on the mammogram suggest a higher probability of early relapse and death among high-risk breast cancer patients. Acta Oncol. 2007;46(8):1178-83.
10. Wang Y, Ikeda DM, Narasimhan B, Longacre TA, Bleicher RJ, Pal S, et al. Estrogen receptor-negative invasive breast cancer: imaging features of tumors with and without human epidermal growth factor receptor type 2 overexpression. Radiology. 2008;246(2):367-75.
11. Yarden Y. Biology of HER2 and its importance in breast cancer. Oncology. 2001;61 Suppl 2:1-13.
12. Hynes NE, Stern DF. The biology of erbB-2/neu/HER-2 and its role in cancer. Biochim Biophys Acta. 1994;1198(2-3):165-84.
13. Seo BK, Pisano ED, Kuzimak CM, Koomen M, Pavic D, Lee Y, et al. Correlation of HER-2/neu overexpression with mammography and age distribution in primary breast carcinomas. Acad Radiol. 2006;13(10):1211-8.
14. Griniatsos J, Vassilopoulos PP, Kelessis N, Agelatou R, Apostolikas N. The prognostic significance of breast tumour microcalcifications. Eur J Surg Oncol. 1995;21(6):601-3.
15. Karamouzis MV, Likaki-Karatza E, Ravazoula P, Badra FA, Koukouras D, Tzorakoleftherakis E, et al. Non-palpable breast carcinomas: correlation of mammographically detected malignant-appearing microcalcifications and molecular prognostic factors. Int J Cancer. 2002;102(1):86-90.
16. Ferranti C, Coopmans DYG, Biganzoli E, Bergonzi S, Mariani L, Scaperrotta G, et al. Relationships between age, mammographic features and pathological tumour characteristics in non-palpable breast cancer. Br J Radiol. 2000;73(871):698-705.
17. Hayes DF. Disease related indicators for a proper choice of adjuvant treatments. Breast. 2011;20 Suppl 3:162-4.
18. Gajdos C, Tartter PI, Bleiweiss IJ, Hermann G, Csepel J, Estabrook A, et al. Mammographic appearance of nonpalpable breast cancer reflects pathologic characteristics. Ann Surg. 2002;235(2):246-51.
19. Dinkel HP, Gassel AM, Tschammler A. Is the appearance of microcalcifications on mammography useful in predicting histological grade of malignancy in ductal cancer in situ? Br J Radiol. 2000;73(873):938-44.
20. Skandalis SS, Labropoulou VT, Ravazoula P, Likaki-Karatza E, Dobra K, Kalofonos HP, et al. Versican but not decorin accumulation is related to malignancy in mammographically detected high density and malignant-appearing microcalcifications in non-palpable breast carcinomas. BMC Cancer. 2011;11:314.
21. Tabar L, Dean PB. Thirty years of experience with mammography screening: a new approach to the diagnosis and treatment of breast cancer. Breast Cancer Res. 2008;10 Suppl 4:3.
22. Tot T, Gere M, Pekar G, Tarian M, Hofmever S, Hellberg D, et al. Breast cancer multifocality, disease extent, and survival. Hum Pathol. 2011;42(11):1761-9.
23. Bick U, Diekmann F. Digital mammography: what do we and what don't we know? Eur Radiol. 2007;17(8):1931-42.